Chinese Specialist Consensus on Diagnosis and Treatment of Osteonecrosis of the Femoral Head.
Wei Sun,Bai-liang Wang,Zi-rong Li
DOI: https://doi.org/10.1111/j.1757-7861.2011.00127.x
2011-01-01
Orthopaedic Surgery
Abstract:Osteonecrosis of the femoral head (ONFH), also called avascular necrosis of the femoral head (AVN), is a common and often refractory disease in the orthopaedic domain. ONFH can be caused by trauma or other factors (nontraumatic). Traumatic ONFH is caused mainly by trauma to the hip, such as femoral neck fracture or hip dislocation. In China, the causes of nontraumatic ONFH are mainly corticosteroid treatment and/or alcohol abuse. ONFH is progressive and about 80% of necrotic femoral heads will collapse within 1 to 4 years in the absence of effective treatment. Collapse of the femoral head (manifested as subchondral fracture and a positive crescent sign) can progress to severe osteoarthritis requiring prosthetic replacement. Nontraumatic ONFH mainly affects young and middle-aged people and bilateral hip involvement is common (approximately 80%). Because the long-term efficacy of total hip arthroplasty in young and middle-aged patients is unpredictable, it is important to perform joint-preserving procedures in the early stages. Based on the suggestions of the Association Research Circulation Osseous (ARCO) and American Academy of Orthopaedic Surgeons, ONFH can be defined as a disease involving the femoral head and characterized by structural change, collapse and joint dysfunction resulting from necrosis caused by interruption or impairment of the blood supply to the femoral head, and subsequent repair of the bone cells and marrow. Based on the diagnostic criteria of the Japanese Investigation Committee and Mont, we propose that the following diagnostic criteria for ONFH are appropriate for China. Clinical symptoms, signs and history which include hip joint pain involving the inguinal region, buttocks and upper leg; limited and painful internal rotation of the hip joint; a history of hip trauma, corticosteroid application and/or alcohol abuse. Radiographic findings: (i) femoral head collapse without joint space narrowing; (ii) calcification band(s) with clear borders inside the femoral head; and (iii) lucent band(s) in subchondral bone (subchondral fracture or positive crescent sign). Radionuclide bone scanning shows a cold area within the hot area of the femoral head. Magnetic resonance imaging of the femoral head shows a banded low signal shadow (banded type) in T1 weighted images or a double-line sign in T2 weighted images. Bone biopsy shows empty osteocytic lacuna with multiple trabecular involvement in >50% of trabeculae as well as necrotic bone marrow. Radiographic findings: (i) femoral head collapse with narrowed joint space; (ii) cystic changes or spotted calcification inside the femoral head; and (iii) flattening of the lateral superior aspect of the femoral head. Radionuclide bone scanning shows a cold or hot area inside the femoral head. Magnetic resonance imaging of the femoral head shows homogenous or heterogeneous low intensity signals with banded changes in T1 weighted images. Two or more positive primary criteria are sufficient for a diagnosis of ONFH. One positive primary criterion with three positive secondary criteria, including at least one positive radiographic sign, are sufficient for a diagnosis of possible ONFH. Clinical examination: a detailed case history, including any hip trauma, consumption of corticosteroids, alcohol abuse and/or anemia, should be taken and clinical features, such as the site and characteristics of any pain and the relationship between pain and weight bearing, should be collected. The physical examination should include assessment of the rotation of the involved hip joint. Radiography: ONFH in its early phases (phases 0 and I) is difficult to identify by radiography. Positive radiographic findings for phase II or greater phases of ONFH include calcification bands, radiotransparent cystic changes, spotty calcification, subchondral fracture and femoral head collapse. The recommended views on radiography include the anteroposterior and frog lateral views, the latter allowing clearer visualization of a necrotic femoral head. Magnetic resonance scan: MR scan is the most reliable method for the diagnosis of early ONFH with a sensitivity and specificity of up to 96%–99%. Typical MRI findings in ONFH include a spirally banded low signal and/or low signal surrounding a region of high or heterogeneous signal at the proximal end of, or across, the residual bone marrow line of the involved femoral head in T1 weighted images. T2 weighted images show a typical double-line sign. Combined T1 and T2 weighted imaging is recommended, supplemented with fat-suppression or short T1 inversion recovery sequencing for a suspected lesion. Sagittal scanning should be used to supplement the routine employment of coronal or transverse scanning, because it allows more precise estimation of the volume of necrosis and visualization of the lesion. Gadolinium-enhanced MRI is superior for the diagnosis of early ONFH. Radionuclide bone scanning: radionuclide bone scanning has high sensitivity and low specificity for diagnosing early ONFH. A cold area within a hot area in a scan for which 99mTC was used is a characteristic manifestation of ONFH, but the presence of pure radionuclide aggregation (hot area) should be differentiated from other joint diseases. This method of examination can be used for screening for the disease at an early phase or for involvement of multiple sites. Single photon emission computer tomography increases the sensitivity rather than the specificity. Computed tomography scanning: CT scanning can clearly display the borders, area, calcified bands, autologous repair and subchondral fractures of ONFH in phases II and III, but is useless for ONFH in phase I. CT scanning surpasses MRI and radiography in displaying any subchondral fracture. A supplemented two-dimensional reconstruction can display the overall femoral head from a coronal view. CT scanning is a useful method for determining the severity of the lesion and the appropriate therapeutic regimen. Other investigations: positron emission tomography, 67Ga or sulfur colloid labeled radioisotope scanning and T2 dynamic MRI blood flow perfusion determination for the diagnosis of early ONFH are currently being testing prior to their clinical application. Moderate/severe osteoarthritis. Typical osteoarthritis is not difficult to differentiate from ONFH, but a slightly narrow joint space and subchondral cystic changes may lead to a misdiagnosis. This disease typically shows calcification and cystic change on CT scanning, low signals on MRI and bony outgrowths at the medial lower margin of the femoral head. Osteoarthritis secondary to acetabular dysplasia. This is not difficult to differentiate from ONFH because it has characteristic radiographic findings including shallow acetabulum, narrowed or absent joint space in the superior lateral region of the femoral head, bony calcification, cystic changes and changes in the corresponding acetabular region similar to the weight-bearing region of the femoral head. Ankylosing spondylitis-related hip arthritis. This is not difficult to identify because of the following typical clinical properties: common in young male patients, bilateral sacroiliac joint involvement, HLA-B27 (+) and a narrowed or absent joint space (or even joint fusion), with a femoral head that is still round. However, patients with a history of long-term corticosteroid administration may develop concomitant ONFH, presenting with a mild to moderate femoral head collapse. Rheumatoid arthritis. This is not difficult to identify on the basis of the following characteristics: a common disease in female patients, narrowed or absent joint space with a round femoral head, frequent subchondral erosion of the femoral head, cystic changes and acetabular erosion. Idiopathic transient osteoporosis of the hip (ITOH). This is caused by transient painful bone marrow edemaand is common in middle-aged people. Its radiographic findings are bone mass reduction at the femoral head, neck and even the trochanter. MRI shows homogenous low signals on T1 weighted images and high signals on T2 weighted images, ranging from the neck to the trochanter of the femoral head, without the banded low signal changes that are seen in ONFH. ITOH can spontaneously resolve 3–6 months after onset. Subchondral incomplete fracture. Clinical features include: common in patients aged more than 60 years, absence of a trauma history, sudden onset of hip pain, walking difficulties and restricted joint movement. Radiography shows slight flattening of the superior lateral aspect of the femoral head. MRI shows subchondral low signals and edema of the surrounding bone marrow on T1 and T2 weighted images, and flaky high signals on T2 fat-suppression images. This fracture is a fracture of tiny trabeculae secondary to osteoporosis. Pigmented villonodular synovitis. This involves the knee joints more often than the hip joints. The features of hip pigmented villonodular synovitis include common in young people, mild to moderate hip pain with claudication and mild restriction of joint movement in the early and middle stages and severe restriction of joint movement in the advanced stage. CT scanning and radiography show cortical erosion at the femoral head, neck and/or acetabulum and mild to moderate narrowing of the joint space. MRI shows extensive synovial hypertrophy involving the overall joint with well distributed low to moderate intensity signals. Femoral head bruise. This is characterized by a hip trauma history, hip pain and claudication. MRI shows moderate intensity signals inside the femoral head on T1 weighted images and high intensity signals on T2 weighted images, more often on the medial side of the femoral head. Synovial herniation pit. This is a benign disease characterized by invasion of hyperplastic synovial tissue into the cortex of the femoral neck. MRI shows low signals on T1 weighted images and small round lesions with high signals on T2 weighted images. It is commonly manifested as asymptomatic erosion of the the cortex in the superior region of the femoral neck. Once ONFH has been diagnosed, scientific staging should be undertaken. This is very helpful for selecting an appropriate treatment plan, accurately assessing the prognosis, and comparing the effects of treatment. We recommend the following staging methods: ARCO staging (Table 1), Steinberg staging (Table 2) and Ficat staging (Table 3). An appropriate treatment strategy should be selected according to the stage, volume of osteonecrosis, age, joint function and occupation of the patient. Currently, there is no single method for managing all variations of ONFH regardless of type, stage and necrotic volume. The treatment methods for ONFH are both non-surgical and surgical and each has its own indications. Whether weight bearing with protection can prevent collapse of the femoral head is controversial. Weight-bearing with crutches is recommended to reduce the pain, whereas use of a wheelchair is not recommended. This is suitable for the pre-collapse stage of ONFH (ARCO Stages 0, I, II) and includes non-steroidal anti-inflammatory analgesics, low molecular weight heparin, Chinese medicine for treating thrombophilia or hypofibrinolysis, alendronate for preventing collapse of the femoral head, vasodilator drugs and drugs for elimination of bone marrow edema. These include extracorporeal shock wave and high-frequency magnetic field therapy. All these methods are useful for alleviating pain and promoting recovery of necrotic bone. The procedures include joint-preservation and joint-replacement surgery. This utilizes the procedures of core decompression, bone grafting, and osteotomy and is suitable for ONFH in ARCO Stages I, II, and IIIA. If the procedure is selected appropriately, it is possible to avoid or delay joint replacement. Core decompression surgery has a long history and recognized benefits in the treatment of ONFH ARCO Stages I and II. It is recommended that a 3-mm wire be used to produce multiple holes under fluoroscopic control in combination with autologous bone marrow cell transplantation or bone morphogenetic protein. This is not recommended for advanced stages (ARCO Stages III and IV). Common methods used in the clinic include vascularized fibular grafting, vascularized iliac bone grafting, and bone grafting with preservation of muscle blood supply. These are suitable for young or middle-aged ONFH patients (ARCO Stages IIC, IIIA, and IIIB). When these surgical procedures are used appropriately, the mid- and long-term effects are good. However, the more severe surgical trauma, technical difficulty, and a certain percentage of complications at the donor site are disadvantages of these procedures. Currently, bone grafting with core decompression via the greater trochanter of the femur or via a femoral neck window is popular. Methods include support bone grafting and impaction bone grafting. Materials used for the bone graft include autologous bone, artificial substitutes, and allograft bone. These are suitable for young or middle-aged ONFH patients in ARCO Stages IIB and IIC with a necrotic volume >25%. Less surgical trauma, technical difficulty, and a small percentage of complications at the donor site are advantages of these procedures. The mid-term result is acceptable but the long-term results are still difficult to predict. The principle of osteotomy is to alter the weight-bearing surface of the femoral head, that is to say, shift the necrotic region out of the weight-bearing surface and make the non-necrotic region the weight-bearing surface. Methods include intertrochanteric varus/valgus osteotomy and transtrochanteric osteotomy. These are suitable for young or middle-aged ONFH patients with moderate Stage II and earlier stages, and middle stage III. When these surgical procedures are used appropriately the results are acceptable, but this surgery can create some technical difficulties for any future arthroplasty. This is still controversial. Some studies suggest that active treatment should be undertaken for large volume necrosis (>30%) and when the necrotic region is located on the weight-bearing surface of the femoral head, rather than waiting for symptoms to occur. Once collapse of the femoral head has progressed to the advanced stages of III, IV or V or there is joint dysfunction and severe pain, total hip replacement should be recommended. Surface replacement, metal-on-metal surface replacement, or the double-acting type of femoral head replacement should be suggested for young patients (<50 years old). These procedures are transitional surgery which preserves more bone quantity for future arthroplasty revision. The procedures above have their own variety of indications, technical requirements and corresponding complications and should be carefully chosen. Total hip arthroplasty for advanced ONFH has positive results. It is generally considered that the long-term efficacy of cementless or mixed-type prosthesis is superior to that of cement prosthesis. The surgical skills required, efficacy and complications of arthroplasty for ONFH vary according to the presence of other disorders. The surgeon should note that: For patients with a long-term history of taking steroids for an underlying disease or some other reason, postoperative infection rates may be increased. For some patients with secondary osteoporosis who have not been weight-bearing for a long time, care should be taken to avoid penetrating the acetabulum during hip replacement surgery. For some patients with failure of a previous preservation procedure, it can be difficult to insert a femoral prosthesis. An arthrodesis procedure can be suitable for younger patients with advanced unilateral ONFH who engage in a lot of physical work. Stage 0: patients with non-traumatic unilateral ONFH who have a definite diagnosis and in whom it is strongly suspected that the opposite hip may also be affected should be closely observed. Assessment by MRI is suggested at 6 monthly intervals. Stages I and II: those asymptomatic patients whose necrotic area is located in a non-weight-bearing region and whose necrotic lesion area <15%, should be closely observed and followed up regularly. Some patients who are symptomatic, or whose necrotic lesion area >15%, should be actively treated. Stages III A and B: a variety of surgical options, including bone grafting, osteotomy, and limited surface replacement, may be selected. Some patients with mild symptoms may be treated conservatively. Stages III C and IV: some younger patients with mild symptoms can be treated by joint-preservation surgery. Other options include surface replacement, total hip replacement and hip arthrodesis. Evaluation of the efficacy of ONFH treatment includes clinical results and radiographic evaluation. Hip function scores (such as the Harris score, the revised Merle d'Auligne score and SF36 evaluation) should be used for evaluation of clinical results. In evaluating imaging results, X-ray films with a template of concentric circles should be used to observe the femoral head shape, joint gap and acetabular changes. For lesions of Stages 0, I, II, MR scanning should be performed. For each patient, the clinical and radiological results are not the same, and should be assessed separately. The Chinese version of this guideline has been published in the Chinese Journal of Orthopaedics, Issue 2, Volume 27, pages 146–148.